(169 days)
No
The summary does not mention AI, ML, or related terms, and the performance studies focus on traditional statistical comparisons and correlations.
No.
The "Intended Use / Indications for Use" states that the device is "intended to quantify tissue blood flow rate," which is a diagnostic function, not a therapeutic one. It quantifies, but does not treat.
Yes
Explanation: The device is intended to quantify tissue blood flow rate, which is a measurement used to assess physiological function and can aid in diagnosing conditions related to blood circulation. The "Prescription Use" indication also suggests it's for medical rather than general wellness purposes.
No
The device description explicitly states it is a "non-invasive probe that is affixed to the fingers or toes" and a "miniaturized clip-on probe," indicating it is a physical hardware device, not software only.
Based on the provided information, the FlowMet-R is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to "quantify tissue blood flow rate" by being "affixed to the fingers or toes." This describes a device that interacts directly with the patient's body to measure a physiological parameter.
- Device Description: The description reinforces this by stating it's a "non-invasive probe that is affixed to the fingers or toes."
- IVD Definition: An IVD device is defined as a medical device used to perform tests on samples such as blood, urine, or tissues, taken from the human body to detect diseases, conditions, or infections. The FlowMet-R does not perform tests on samples taken from the body. It measures a physiological parameter in vivo.
Therefore, the FlowMet-R falls under the category of a non-invasive diagnostic device that measures a physiological parameter directly from the patient, rather than an IVD device that analyzes samples taken from the patient.
N/A
Intended Use / Indications for Use
The FlowMet-R is a non-invasive probe that is affixed to the fingers or toes and intended to quantify tissue blood flow rate.
Product codes
DPW
Device Description
The FlowMet-R™ is a non-invasive probe that is affixed to the fingers or toes and intended to quantify tissue blood flow rate.
Both the PeriCam PSI and the FlowMet-R™ use the same fundamental technology for the assessment of peripheral tissue blood flow: Laser Speckle Imaging. The main difference between the two devices is the location and placement of the source (laser) and detector (camera). For the predicate device, the PeriCam PSI, the source and detector are on the same side of the sample being imaged; whereas in the FlowMet-R™, the source and detector are on opposite sides of one another. The other difference is that the FlowMet-R™ is fixed to the sample of interest, much like a pulse oximeter, which offers two key benefits: 1) reduced motion artifact 2) reduced light (laser) exposure to the eyes, thus making the FlowMet-R™ device potentially safer than the predicate.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Laser Speckle Imaging
Anatomical Site
fingers or toes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
clinician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The FlowMet-R™ system was compared to the legally marketed predicate device (K120884) and to a laser Doppler flowmeter (K974285) in nonclinical benchtop and clinical testing.
First Benchtop Test:
- Study type: Benchtop test comparing output from FlowMet-R™ with PeriCam PSI system under known flow rate conditions.
- Sample size: Not explicitly stated but involved concurrent measurements of the same sample.
- Key results: Demonstrated similar response and high linearity (FlowMet-R™ R² > 0.999, PeriCam PSI R2 > 0.95) between data output and flow rate for both devices, showing equivalence.
Second Benchtop Test:
- Study type: Benchtop test to determine the impact of skin coloration on FlowMet-R™ measurements using tissue analogs.
- Sample size: Not explicitly stated.
- Key results: Demonstrated that the degree of absorption within a skin tissue analog, and thus skin color, does not significantly affect the flow rate within the sample as determined by the FlowMet-R™.
First Clinical Test:
- Study type: Clinical test to determine the relationship between FlowMet-R™ measurements and a contact laser Doppler flowmeter (PeriFlux System 5000).
- Sample size: 10 patients (5 male, 5 female).
- Key results: Demonstrated that the FlowMet-R™ system measures the expected decrease in flow rates during occlusion, and that the resulting measured decrease is within +/-22% of the laser Doppler system. Flow measurements from the FlowMet-R™ and laser Doppler devices were found to be significantly correlated for all patients with significant p values (0.8.
Second Clinical Test:
- Study type: Clinical test to determine if significant differences in flow values exist resulting from differing skin colors.
- Sample size: 91 patients (181 total limbs, 84 females, 97 males).
- Key results: An ANOVA test demonstrated that there was no significant difference in the mean flow value among all groups (White/Caucasian (N=144), Hispanic/Latino (N=23), Asian (N=11), and African American (N=3)), indicating skin color did not significantly affect FlowMet-R™ measurements.
Key Metrics
- Linearity: FlowMet-R™ R² > 0.999, PeriCam PSI R2 > 0.95
- Difference in measured decrease vs. laser Doppler system: within +/-22%
- Correlation coefficient (clinical test): >0.8
- p values (clinical test):
§ 870.2100 Cardiovascular blood flowmeter.
(a)
Identification. A cardiovascular blood flowmeter is a device that is connected to a flow transducer that energizes the transducer and processes and displays the blood flow signal.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains two logos. The logo on the left is the Department of Health & Human Services - USA logo. The logo on the right is the FDA U.S. Food & Drug Administration logo. The FDA logo is in blue.
Laser Associated Sciences, Inc. Sean White President and CEO 16 Foxglove Way Irvine, California 92612
February 27, 2019
Re: K182494
Trade/Device Name: FlowMet-R Regulation Number: 21 CFR 870.2100 Regulation Name: Cardiovascular Blood Flowmeter Regulatory Class: Class II Product Code: DPW Dated: August 31, 2018 Received: September 11, 2018
Dear Sean White:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Stephen C. Browning -S5
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K182494
Device Name FlowMet-R
Indications for Use (Describe)
The FlowMet-R is a non-invasive probe that is affixed to the fingers or toes and intended to quantify tissue blood flow rate.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
Submitter's Name and Address
Laser Associated Sciences, Inc. 16 Foxglove Way Irvine, CA 92612 Tel: (949) 662-8892 Contact Person for this submission: Sean White
Date of Summary
The summary was prepared 15 of June 2018 and revised 21 of February 2019.
Device Information
| Trade name: | FlowMet-R™ |
|---|---|
| Model No: | FlowMet-R™ |
| Type of product: | Finished product |
| Panel: | Cardiovascular |
| Common Name: | Peripheral Blood Flow Monitor |
| Classification Name: | Cardiovascular blood flow meter |
| Indications for Use: | The FlowMet-R is a non-invasive probe that is affixed to |
| the fingers or toes and intended to quantify tissue blood | |
| flow rate. | |
| Class: | II |
| Classification Regulation: | 870.2100 |
| Product Code: | DPW |
| Pre-Submission No. | Q171467 |
Predicate Device Information
| Trade name: | PeriCam PSI |
|---|---|
| Model No: | PeriCam PSI NR, PeriCam PSI HR |
| 510(k) No: | K120884 |
| Type of product: | Finished product |
| Panel: | Cardiovascular |
| Common Name: | Blood Perfusion Imager |
| Classification Name: | Cardiovascular blood flow meter |
| Indications for Use: | The PeriCam PSI is intended for non-invasive two- |
| dimensional imaging of peripheral tissue blood perfusion. | |
| Class: | II |
4
| Classification Regulation: | 870.2100 |
|---|---|
| Product Code: | DPW |
| 510(k) No. | K120884 |
Device Description
Intended Use of the Device
The FlowMet-R™ is a non-invasive probe that is affixed to the fingers or toes and intended to quantify tissue blood flow rate.
Summary of technological characteristics of Device and Predicate Device
Both the PeriCam PSI and the FlowMet-R™ use the same fundamental technology for the assessment of peripheral tissue blood flow: Laser Speckle Imaging. The main difference between the two devices is the location and placement of the source (laser) and detector (camera). For the predicate device, the PeriCam PSI, the source and detector are on the same side of the sample being imaged; whereas in the FlowMet-R™, the source and detector are on opposite sides of one another. The other difference is that the FlowMet-R™ is fixed to the sample of interest, much like a pulse oximeter, which offers two key benefits: 1) reduced motion artifact 2) reduced light (laser) exposure to the eyes, thus making the FlowMet-R™ device potentially safer than the predicate.
Comparison to the predicate device K120884, PeriCam PSI
Laser safety
The FlowMet-R™ and PeriCam PSI are classified as a Class I laser product according to IEC 60825-1:2014. Additionally, the FlowMet-R™'s clamshell housing blocks the laser output when not in use or when applied to a digit.
Acquisition rate
The FlowMet-R™ acquires data at a higher speed (250fps) vs. the PeriCam PSI (~10fps). This allows the FlowMet-R™ to display the data in real time and provide feedback to the clinician.
Affixed sensor
The PeriCam PSI instrument is a mounted imaging head on a control arm, whereas the FlowMet-R™ is a miniaturized clip-on probe, designed to be affixed to the fingers or toes. LAS has taken steps to reduce hazards associated with skin contact by using biocompatible materials and certifying these skin-contacting materials per ISO 10993-1.
Performance Data
The FlowMet-R™ system was compared to the legally marketed predicate device (K120884) and to a laser Doppler flowmeter (K974285) in nonclinical benchtop and clinical testing.
5
The first benchtop test compared output from the FlowMet-R™ system with the PeriCam PSI system under known flow rate conditions. Both systems measured the same sample concurrently: a tissue analog containing fluid pumped through at predetermined volumetric flow rates. The flow rates were varied from 2-20ml/min, which includes and exceeds the normal human physiological range. At each flow rate, data was collected concurrently from both systems for a specified length of time (30 seconds). The test results demonstrate similar response and high linearity (FlowMet-R™ R² > 0.999, PeriCam PSI R2 > 0.95) between data output and flow rate for both devices, showing equivalence between the performance of FlowMet-R™ and PeriCam PSI in determining flow rate within the sample.
The second benchtop test was performed to determine the impact of skin coloration on FlowMet-R™ measurements. FlowMet-R™ data was collected under known flow rate conditions using a tissue analog. Skin colors were simulated by creating silicone-based skin analogs with varving optical absorption (us). which was controlled by adding different concentrations of nigrosine dye. The test results demonstrate that the degree of absorption within a skin tissue analog, and thus skin color, does not significantly affect the flow rate within the sample as determined by the FlowMet-R™.
The first clinical test was performed to determine the relationship between FlowMet-RTM measurements and a contact laser Doppler flowmeter (PeriFlux System 5000). Device probes were placed on the same digit, adjacent to one another, to measure analogous tissue volumes. Data was collected from 10 patients before, during, and after vascular disruption induced via brachial artery occlusion. 5 patients were male and 5 patients were female. The test results demonstrate that the FlowMet-R™ system measures the expected decrease in flow rates during occlusion, and that the resulting measured decrease is within +/-22% of the laser Doppler system. Flow measurements from the FlowMet-R™ and laser Doppler devices were found to be significantly correlated for all patients with significant p values (0.8.
The second clinical test was performed to determine if there exists significant differences in flow values resulting from differing skin colors. FlowMet-R™ blood flow and sensor intensity data was collected from 91 patients (181 total limbs, 84 of which were from females, and 97 of which were from males). Data was grouped by ethnicity/skin color: White/Caucasian (N=144), Hispanic/Latino (N=23), Asian (N=11), and African American (N=3). An ANOVA test demonstrated that there was no significant difference in the mean flow value among all groups, indicating the skin color did not significantly affect FlowMet-R™ measurements. Additionally, the difference in mean transmitted intensity between light-skinned (White/Caucasian) patients and any other group demonstrated that skin tone did not significantly decrease light source throughput.
Conclusion
The FlowMet-R™ and the PeriCam PSI both use the fundamental principles of Laser Speckle Imaging for the measurement of blood hemodynamics in tissue, by quantifying
6
the change in speckle contrast due to the blurring phenomena associated with moving objects. The FlowMet-R™'s differing source and detector configuration makes the FlowMet-R™ less susceptible to motion artifact and reduces the light (laser) exposure to the eyes. The FlowMet-R™ demonstrated substantial equivalence to the PeriCam PSI through benchtop testing and significant correlation to a laser Doppler flowmeter in clinical evaluation. Combined benchtop and clinical testing demonstrated that FlowMet-RTM measurements are not significantly affected by physiological differences in skin tone.